-+ 0.00%
-+ 0.00%
-+ 0.00%

Contineum Therapeutics Q3 EPS $(0.40) Beats $(0.43) Estimate

Benzinga·11/06/2024 21:54:39
Listen to the news
Contineum Therapeutics (NASDAQ:CTNM) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.43) by 6.98 percent.